학술논문
Effective preclinical treatment of KRAS mutant lung cancers with a combination of MLN0128, an investigational novel mTORC1/2 inhibitor, and a selective MEK inhibitor
Document Type
Journal
Source
Subject
Language
English
ISSN
15388514